GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK plc has announced provisional dividend dates for the year 2026, outlining key ...

A bold guidance raise, fresh FDA approval, and pipeline deals set the stage for GSK's post-Walmsley transformation.

Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer medicines posted double digit ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £16.00. The company’s shares opened today at p1,765.00. Take ...

GSK Pharma share price fell 3 per cent after it reported a lower-than-expected top-line for the second quarter of the current ...

GSK Plc raised its profit and sales forecasts for the year, aided by its HIV and immunology medicines, in Emma Walmsley’s ...

On October 27, Jefferies in​itiated coverage on​ GSK plc (NYSE:GSK) wi​th a Buy rating​ a‍nd a price target of 2,000 G‌Bp.

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for ...

Unsurprisingly, GSK plc's ( LON:GSK ) stock price was strong on the back of its healthy earnings report. However, ...

Next set to turn heads with special dividend, upbeat Q3 numbers from GSK bolster FY outlook,, WH Smith FY numbers to follow ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...